NovoCure Limited (NVCR)

NovoCure Revenue

NovoCure had revenue of $174.06M in the quarter ending March 31, 2026, with 12.30% growth. This brings the company's revenue in the last twelve months to $674.41M, up 8.48% year-over-year. In the year 2025, NovoCure had annual revenue of $655.35M with 8.28% growth.

• Revenue (ttm): $674.41M
• Revenue Growth: +8.48%
• P/S Ratio: 2.36
• Revenue / Employee: $420,196
• Employees: 1,605
• Market Cap: 1.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	655.35M	50.13M	8.28%
Dec 31, 2024	605.22M	95.88M	18.82%
Dec 31, 2023	509.34M	-28.50M	-5.30%
Dec 31, 2022	537.84M	2.81M	0.53%
Dec 31, 2021	535.03M	40.67M	8.23%
Dec 31, 2020	494.37M	143.05M	40.72%
Dec 31, 2019	351.32M	103.25M	41.62%
Dec 31, 2018	248.07M	71.04M	40.13%
Dec 31, 2017	177.03M	94.14M	113.57%
Dec 31, 2016	82.89M	49.80M	150.52%
Dec 31, 2015	33.09M	17.60M	113.60%
Dec 31, 2014	15.49M	5.13M	49.53%
Dec 31, 2013	10.36M	-	-

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error